Ha Thi Thu Nguyen

Ha Thi Thu Nguyen

Auto-generated profile, based on publicly available information

Ha Thi Thu Nguyen

National Center for Assisted Reproduction, National Hospital of Obstetrics and Gynecology, Hanoi, Vietnam (Nguyen)

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2021 in Radiology Case Reports
Verified
Journal Article
Open access
NANguyen Duy Anh
Nguyen Duy Anh
NHNguyen Xuan Hai
Nguyen Xuan Hai
NHNguyen-Thi Thu Ha
Nguyen-Thi Thu Ha
NTNguyen Khac Toan
Nguyen Khac Toan
PTPhan-Thi Huyen Thuong
Phan-Thi Huyen Thuong
Nguyen Minh DucNguyen Minh Duc
Nguyen Minh Duc
Retroperitoneal ectopic pregnancy (REP) is a rare obstetric condition caused by the mislocalization of the gestational mass. The unexpected location often results in missed or delayed diagnoses, which can complicate the treatment process. We report the case of a 34-year-old Asian woman who presented to the hospital 31 days after embryo transfer with mild vaginal bleeding. A history of bilateral salpingectomies was established. Two operations were performed before we were able to successfully remove the gestational sac from the retroperitoneal cavity. The histologic finding suggested an interesting migration pathway for the pregnancy. REP should be considered when a visible gestational sac cannot be detected on ultrasound in the expected locations, particularly among patients who undergo treatment using assisted reproductive techniques (ART), and have a history of bilateral salpingectomies. Magnetic resonance imaging (MRI) plays a vital role in diagnosing REP and guiding surgical interventions. A multidisciplinary team is necessary to treat REP, and monitoring beta-human chorionic gonadotropin (βHCG) levels and histologic findings remain essential during follow-up.

1 April 2022 in International Journal of Women's Health
Verified
Journal Article
Open access
PDF file
NANguyen Duy Anh
Nguyen Duy Anh
HHHo Sy Hung
Ho Sy Hung
NSNguyen Thi Sim
Nguyen Thi Sim
NHNguyen Thi Thu Ha
Nguyen Thi Thu Ha
DNDuc Lam Nguyen
Duc Lam Nguyen
PTPhan Thi Huyen Thuong
Phan Thi Huyen Thuong
Objective: To evaluate the surgery outcomes of fetoscopic laser ablation (FLA) for selective umbilical cord in treating twin-twin transfusion syndrome (TTTS) with special conditions and neonatal outcomes post-operation. Methods: A prospective study, 21 monochorionic diamniotic (MCDA) twins diagnosed with TTTS stage II–IV according to Quintero classification from 16 to 26 weeks of gestation, among that, 12 cases of TTTS stage II with selective intrauterine growth restriction (sIUGR), 6 cases of TTTS stage II with proximate cord insertions, 3 cases of TTTS stage IV underwent fetoscopic laser ablation for the selective fetal reduction at Hanoi Obstetrics and Gynecology Hospital from September 2019 to July 2021. Complications and surgical outcomes were noted. Prenatal care was carried out every 2 weeks post operation until birth. Newborn neurologic complications were assessed at birth, three months, and six months after birth using Denver II test and magnetic resonance imaging (MRI). Results: The mean gestational age at operation was 20.30 weeks. The average operation duration was 39.52 minutes. No complications of operation, such as bleeding or infection, were recorded. The mean gestational age at birth was 34.70 ± 4.33 weeks, with a mean duration of 12.97 ± 6.87 weeks between intervention and delivery. The survival rate of newborns after the operation was 90.48%. There were two stillbirths (9.52%) within seven days after the operation. No short-term neurological complications have been reported with follow-up of the newborn to 6 months after birth. Conclusion: Our study showed that fetoscopic laser ablation of selected fetal reduction surgery for treatment of special conditions of TTTS had no complications of operation, high neonatal survival result (90.48%), no short-term neurological complications. This should be considered for TTTS in cases of indication.

1 February 2025 in AJOG Global Reports
Verified
Journal Article
Open access
HNHa Thi Thu Nguyen
Ha Thi Thu Nguyen
GDGiang Thi Tra Duong
Giang Thi Tra Duong
TLThanh Hoang Luong
Thanh Hoang Luong
DDDat Tuan Do
Dat Tuan Do
TPThuong Thi Huyen Phan
Thuong Thi Huyen Phan
ANAnh Duy Nguyen
Anh Duy Nguyen
The term “elective induction of labor (eIOL)” refers to the practice of inducing labor before the due date in the absence of medical indication. In 2022, the American College of Obstetricians and Gynecologists (ACOG) recommended that eIOL be considered for healthy women at 39 weeks of gestation. However, the acceptance of eIOL among pregnant women is crucial. Understanding pregnant women's perspectives on this issue is essential for developing strategies to shift public perceptions of eIOL. To evaluate the opinion and acceptance of low-risk pregnant women regarding elective induction of labor at 39th week of gestation. From January 2022 to January 2023, we conducted a survey of low-risk pregnant women attending routine obstetrics at Hanoi Obstetrics and Gynecological Hospital, Hanoi, Vietnam, at 2 intervals: 36 weeks and 39 weeks of gestation. The first survey included questions regarding basic demographics, obstetric history, and participants' opinions and acceptance of labor induction, with a particular focus on eIOL at 39 weeks of gestation in the absence of medical indications. The women's acceptance was asked for a second time at 39 weeks, and in-depth interviews were conducted with those who changed their minds between the 2 surveys. For 200 pregnant women who participated in the study at 36 weeks, the 3 most common reasons for IOL prior to the due date were maternal indications, fetal indications, and a convenient day for pregnant women, about 88%, 87%, and 80%, respectively. Women not opting for eIOL were concerned about the risk of harm to the fetus (53%) and increasing infection complications (33%). Among 177 pregnant women who completed the second survey, the rate of eIOL acceptance was decreased compared to the first time (40.1% vs 54.5%, respectively). Twenty-eight women altered their decision from acceptance to rejection of eIOL due to apprehension about the risk associated with labor induction (43%) or impacts from others, including medical staff (25%) and relatives (21%). Four out of 8 women conversed to accept eIOL at the 39th week of gestation to choose a date of birth. Awareness of the induction of labor among pregnant women in Vietnam remains limited. More than half of women who do not support eIOL believe it could be harmful to the fetus. The acceptance rate for eIOL declines as the pregnancy approaches the due date because of adverse impacts from relatives and medical staff. These findings underscore the importance of comprehensive medical counseling for pregnant women and their families, as well as improving the healthcare providers’ awareness regarding the advantages and disadvantages of induction of labor.

24 January 2026 in AJOG Global Reports
Verified
Journal Article
Open access
ANAnh Duy Nguyen
Anh Duy Nguyen
HNHa Thi Thu Nguyen
Ha Thi Thu Nguyen
TNThuy Bien Nguyen
Thuy Bien Nguyen
DDDat Tuan Do
Dat Tuan Do
GDGiang Thi Tra Duong
Giang Thi Tra Duong
TLThanh Hoang Luong
Thanh Hoang Luong
Placenta accreta spectrum (PAS) is a life-threatening condition often managed by cesarean hysterectomy, resulting in numerous negative impacts on women's health. Most PAS cases do not involve parametrial invasion and may not require aggressive or complex surgical approaches. However, no simplified uterus-sparing technique exists for this subgroup. Therefore, we developed a novel surgical approach, “Simple Conservative surgical Approach for Placenta Accreta Spectrum – SCAPAS,” tailored for PAS without parametrial invasion. SCAPAS included eight main steps. To evaluate the efficacy and safety of SCAPAS in conservative surgical management of women with PAS without parametrial invasion. This prospective study was conducted from January 2022 to June 2023 at Hanoi Obstetrics and Gynecology Hospital. Sixty-three women with PAS without suspected parametrial invasion, according to the prenatal ultrasound staging system for PAS disorder, underwent elective cesarean delivery using the SCAPAS technique at ≥35 weeks of gestation. Maternal and fetal outcomes were collected. Successful cases were defined as those achieved uterine conservation following SCAPAS without any life-threatening complications. Of the 63 cases, 74.6% were patients under 35, and 66.7% had a history of two or more cesarean sections. The majority of women were diagnosed with PAS2 (69.8%). The success rate of SCAPAS was 85.7%. Success rates for placenta accreta, increta, and percreta were 100%, 82.4%, and 81.8%, respectively. The overall median intraoperative blood loss was 1200 mL (range 400–2500 mL), and the median duration of surgery was 80 minutes (range 35–124 minutes), with a mean interval from skin incision to fetal delivery was 30 minutes. Bladder injury and mild wound infections occurred in 6.3% (4/63) and 4.8% (3/63) cases, respectively. No patient required re-laparotomy. Total 20.6% of newborns had an Apgar score of less than 7 at 1 minute, but all recovered after 5 minutes. SCAPAS is a simple, safe, and effective surgical approach for conservative management of PAS without suspected parametrial invasion. Further studies are needed to develop a preoperative classification based on location, area, and degree of invasion to improve outcomes in PAS patients.

1 January 2021 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
ANAnh Duy Nguyen
Anh Duy Nguyen
HNHa Thi Thu Nguyen
Ha Thi Thu Nguyen
GGGiang Thi Tra Giang
Giang Thi Tra Giang
TPThuong Thi Huyen Phan
Thuong Thi Huyen Phan
DDDat Tuan Do
Dat Tuan Do
YVYves Ville
Yves Ville
Background: Cesarean scar myometrial defect also known as niche is associated with postmenstrual spotting, suprapubic pain and secondary infertility. Hysteroscopic isthmoplasty has been proposed in the treatment of niche. This study aims to determine the safety and effectiveness of hysteroscopic isthmoplasty in postmenstrual spotting treatment and improvement of natural conceiving after surgery. Materials and method: A prospective study was performed at Hanoi Obstetrics and Gynecology Hospital, Vietnam between June 2018 and June 2019. We studied women who developed postmenstrual spotting related to niches and had desired to conceive for more than six months. Women with residual myometrium less than 2.5 mm were excluded. Twenty-three eligible women underwent hysteroscopic isthmoplasty with four main steps, including identification of relevant anatomy, resection of the cephalad edge of fibrosis, resection of the caudal edge of fibrosis, and ablation of the niche base. Participants were followed up at 1, 3, and 6 months postoperatively. Results: The mean surgical duration was 17 minutes, and no complications took place. The number of women with improved postmenstrual spotting symptoms after 1, 3, and 6 months were 39.1% (9/23), 61.9% (13/21) and 68.8% (11/16), respectively. Suprapubic pain resolved in 94% (15/16) of the women in the first month. The rate of spontaneous pregnancies within 6 months of isthmoplasty was 30.4% (7/23). There were no differences in depth niche and residual myometrium thickness on ultrasound in the period before and after hysteroscopy. Conclusion: Our study supports that hysteroscopic isthmoplasty is a safe and effective procedure for women with a niche and postmenstrual spotting and wish to conceive.